View allAll Photos Tagged Cancer!
These days, the oncologists use a Gleason score for diagnosing and staging prostate cancer. It helps the oncologists assess the extent and aggressiveness of the disease as well as to determine the treatment for the patient.
Visit sgccri.org/blog/
81 year old woman with a 2 year history of rectal bleeding. Biopsy showed moderately differentiated adenocarcionma.
October is Breast Cancer Awareness Month, and pink is the color used to show support for efforts to find a cure...Stand Proud and Keep Fighting!
KaTink (formerly PNP) has a vast variety of props, poses and backgrounds for all your SL photographic needs. Props, poses, photography, wedding poses, single poses, runway poses, action poses, couples poses. fantasy poses, backgrounds, backdrop, PNP,
KaTink - Poses and Photographic Artistry
maps.secondlife.com/secondlife/Phoenix%20Determined/69/15...
marketplace.secondlife.com/stores/65727
Pictures Taken by KaTink Creator & Photographer : Maliah Naidoo
A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), according to a report published Online First by Archives of Surgery.
Thyroid cancer is on the rise on the United States and most of the increase is due to PTC, although the authors write that it is debatable whether the increase is caused by an enhanced risk of cancer or an increase in detection. Obesity is recognized as a risk factor for a variety of cancers, the authors provide as study background.
"Our study shows that those patients with increasing BMI have a progressively increasing risk in presenting with late-stage PTC. This finding is especially seen in the obese and morbidly obese populations," the researchers comment.
Avital Harari, M.D., and colleagues at the UCLA David Geffen School of Medicine, Los Angeles, reviewed the medical records of all patients older than 18 who underwent total thyroidectomy (removal of most or all of the thyroid gland) as an initial procedure for PTC or its variants from January 2004 through March 2011.
The final analysis included 443 patients with an average age of 48.2 years. Patients were divided into four BMI (body mass index) groups: normal (18.5-24.9), overweight (25-29.9), obese (30-39.9) and morbidly obese (=40).
"Greater BMI was associated with more advanced disease stage at presentation. Specifically, the obese and morbidly obese categories presented more as stage III or IV disease," according to the study results.
Researchers also note the obese and morbidly obese groups also presented with a higher prevalence of PTC tall cell variant, "suggesting that these groups have a higher risk of more aggressive tumor types."
"Given our findings, we believe that obese patients are at a higher risk of developing aggressive thyroid cancers and thus should be screened for thyroid cancer by sonography, which has been shown to be more sensitive in detecting thyroid cancer than physical examination alone," the authors conclude.
In an invited critique, Quan-Yang Duh, M.D., of the University of California, San Francisco, writes: "Harari and colleagues from UCLA (University of California, Los Angeles) showed us one more reason to be concerned about the current obesity epidemic - obese patients have more advanced thyroid cancer."
Duh continues: "This parallel increase in the rates of obesity and thyroid cancer is intriguing, but without a much larger population study, we cannot determine whether obesity causes thyroid cancer. However, the authors found that higher body mass index is associated with a later stage of thyroid cancer."
"For obese patients with papillary thyroid cancer, the bad news is that the cancer is likely to be more advanced. The good news is that thyroid operation remains safe even in obese patients with advanced disease," Duh concludes. thyroidcancer.livejournal.com/767.html
We can. I can.
The first step in driving progress around cancer is to push for actions that we know will improve survival rates and give cancer patients a better quality of life.
- Download this Fact Sheet - We can inspire action, take action - WCD2017 - English.
- World Cancer Day 2016-2018 Key Messages.
- World Cancer Day 2016-2018 : there is a lot you can do!
- WCD website, share materials and ways to help.
eing a breast cancer patient is quite frightening. It’s like turning of the life upside down. Breast cancer care becomes the top priority of your life.
for complete info visit our breastlight blog
This morning a hummingbird appeared outside my window, hovered, and then disappeared. Wildlife rocks! It reminded me that at anytime something unexpected can happen that will brighten my day.
Excited for tomorrow, ready for the unexpected.
To recap: On Sunday, July 1st, I completed Cycle 45 Week 1. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
The OZ-08MMS Cancer was developed by the organization OZ as its second aquatic mobile suit. Despite being a mobile suit the Cancer lacked the basic humanoid appearance of other mobile suits and was designed without legs, strictly limiting its movement capabilities to aquatic environments such as the ocean. In place of legs the Cancer's primary propulsion systems were hydrojet engines built into the main body, while maneuvering was handled through ring of reversible side-spinning propeller blades on each arm.
The Cancer's primary weapons systems were four torpedo launchers in its arms. Those same arms mounted pincer-like claws with which the Cancer could grapple targets. Each claw contains two of the Cancer's four torpedo launchers.
This morning I sat on a rocky formation watching the water rushing back and forth. I love the sounds the waves make and enjoy seeing wildlife flying overhead. Nature makes me happy.
To recap: On Sunday, June 10th, I completed Cycle 44 Week 2. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
In my doctors' office I rang this bell today in celebration of five years of being
"cancer free" after three bouts with Non-Hodgkins Lymphoma Cancer!!!!!
It brought goosebumps, teary eyes, and hugs!!! Praise God for His love
and mercy to carry one through life's times of testing and trials!!!
Photo: Life is full of adventure that begin with the first step outside your home.
The results from my February monthly blood test were missing the m protein value. My particular type of multiple myeloma is less common and it is not always possible to get an m protein value - the best measure to determine my cancer levels. However, looking at less specific measures on my test results, I believe my cancer levels are similar to January (estimate between 13 and 14). The additional chemo seems to be keeping my cancer levels reasonably stable, however I remain hopeful for lower cancer levels for March.
M protein (g/L) (0 = no cancer detected)
Feb = value missing (estimate between 13 and 14)
Jan = 13 (began Ninlaro chemo - 2 weeks prior)
Dec = between 10 and 11
Nov = 8
July = 3.0 (ended dexamethasone - steroid)
Feb 2015 (began Pomalyst chemo + dexamethasone) = 36.1
Yes, everything takes longer than usual and I am quite forgetful, but each morning I wake up happy and ready for the day.
To recap: On Sunday, February 25th, I completed Cycle 40 Week 3. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
See Blogpost
(CC) Phillip Jeffrey. www.fadetoplay.com. Feel free to use this photo. I request that you link back to the original picture on Flickr and credit as shown above.
166/365
Camera: Canon XSi
Lens: 50mm f/1.4
Exp: ISO 800, f/5.6, 1/15
My cancer levels (45.8 igG from 35.7) have significantly spiked. On Tuesday, Sept 11, I had my specialist appointment and learned that I will need to begin a 4th cancer treatment (cancer drug + dextramethasone) if my levels increase again. My blood test rather than every 3 months will be monthly.
These will be tough days ahead for mentally and physically. I will focus on remaining positive.
There are everyday challenges living with multiple myeloma while on chemo. It would be easy for me to dwell endlessly on the tasks I’m no longer able to perform, the activities that I can no longer participate in, or the permanent changes to my body due to long-term treatment. However, I believe that type of negativity would make me sad, isolated, and feeling sorry for myself.
Instead, I emphasize positivity in my life. I focus on what I can do and count each day I get out of my bed as a success. I counter chemo side effects and symptoms of my disease (both known and unknown), with a belief that cancer will not bring me down. I do fun things that make me happy. I try to laugh each day.
I like to reward myself with mental gold stars each time I do something challenging such as navigating transit successfully to visit a friend, helping someone lost with directions, or coordinating my next specialist appointment. Emphasizing my successes helps me maintain a positive outlook on life. I’m all about moving forward, at a pace that is acceptable to me.
Cancer is what I have, it is not who I am.
To recap: On Sunday, March 4th, I completed Cycle 40 Week 4. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
World Cancer Day 2016 with "Support Cancer Care 4 All" at the IAEA headquarters in Vienna, Austria. 3 February 2016
Photo Credit: Dean Calma / IAEA
Used to have chemotherapy back in late 2008 to treat Stage IV Kidney Cancer.
This is the needle that went into my port-a-cath and then the drugs are the two back syringes.
(CC) Phillip Jeffrey. www.fadetoplay.com. Feel free to use this photo. I request that you link back to the original picture on Flickr and credit as shown above.
My chemo treatment is continuing, however I am responding well to treatment. My cancer levels (igG) have dropped from 19.0 (March) down to 11.8 (May).
Focused on staying positive and being happy.